Sign inGet started

Salas Eduardo Rene

Insider CIK 1924188 · ADMA Director · ITCI Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ADMA ADMA BIOLOGICS, INC. A Award deriv2026-02-092026-02-1117,730— $017,730SEC↗
ADMA ADMA BIOLOGICS, INC. A Award2026-02-092026-02-1110,690— $021,579SEC↗
ITCI Intra-Cellular Therapies, D To issuer deriv2025-04-022025-04-027,009— $00SEC↗
ITCI Intra-Cellular Therapies, D To issuer deriv2025-04-022025-04-022,951— $00SEC↗
ITCI Intra-Cellular Therapies, D To issuer deriv2025-04-022025-04-024,322— $00SEC↗
ITCI Intra-Cellular Therapies, D To issuer deriv2025-04-022025-04-0220,000— $00SEC↗
ITCI Intra-Cellular Therapies, D To issuer deriv2025-04-022025-04-0216,757— $00SEC↗
ITCI Intra-Cellular Therapies, D To issuer2025-04-022025-04-021,567$132.00 $206.8K0SEC↗
ADMA ADMA BIOLOGICS, INC. A Award deriv2025-02-192025-02-2116,279— $016,279SEC↗
ADMA ADMA BIOLOGICS, INC. A Award2025-02-192025-02-2110,889— $010,889SEC↗
ADMA ADMA BIOLOGICS, INC. A Award deriv2024-12-302025-01-0220,011— $020,011SEC↗
ITCI Intra-Cellular Therapies, M Exercise deriv2024-06-232024-06-251,567— $00SEC↗
ITCI Intra-Cellular Therapies, M Exercise2024-06-232024-06-251,567— $01,567SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2024-06-142024-06-184,322— $04,322SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2024-06-142024-06-182,951— $02,951SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2023-06-232023-06-271,567— $01,567SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2023-06-232023-06-277,009— $07,009SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2022-06-092022-06-1316,757— $016,757SEC↗
ITCI Intra-Cellular Therapies, A Award deriv2022-04-202022-04-2120,000— $020,000SEC↗